116 related articles for article (PubMed ID: 142579)
1. Treatment of advanced adenocarcinoma of the pancreas with combinations of streptozotocin plus 5-fluorouracil and streptozotocin plus cyclophosphamide.
Moertel CG; Douglas HO; Hanley J; Carbone PP
Cancer; 1977 Aug; 40(2):605-8. PubMed ID: 142579
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer.
Wiggans RG; Woolley PV; Macdonald JS; Smythe T; Ueno W; Schein PS
Cancer; 1978 Feb; 41(2):387-91. PubMed ID: 147131
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
Bukowski RM; Abderhalden RT; Hewlett JS; Weick JK; Groppe CW
Cancer Clin Trials; 1980; 3(4):321-4. PubMed ID: 6448716
[TBL] [Abstract][Full Text] [Related]
4. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma.
Moertel CG; Hanley JA; Johnson LA
N Engl J Med; 1980 Nov; 303(21):1189-94. PubMed ID: 6252466
[TBL] [Abstract][Full Text] [Related]
5. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
Togni P; Sessa C; Varini M; Cavalli F
Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
[TBL] [Abstract][Full Text] [Related]
6. A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma.
Kelsen D; Hudis C; Niedzwiecki D; Dougherty J; Casper E; Botet J; Vinciguerra V; Rosenbluth R
Cancer; 1991 Sep; 68(5):965-9. PubMed ID: 1833042
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
Oster MW; Gray R; Panasci L; Perry MC
Cancer; 1986 Jan; 57(1):29-33. PubMed ID: 2934124
[TBL] [Abstract][Full Text] [Related]
8. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
[TBL] [Abstract][Full Text] [Related]
9. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
Merrin C; Etra W; Wajsman Z; Baumgartner G; Murphy G
J Urol; 1976 Jan; 115(1):86-8. PubMed ID: 1107604
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin.
Chernicoff D; Bukowski RM; Groppe CW; Hewlett JS
Cancer Treat Rep; 1979 May; 63(5):795-6. PubMed ID: 222449
[TBL] [Abstract][Full Text] [Related]
12. Mitoxantrone combined to vincristine, cyclophosphamide and fluorouracil in advanced breast cancer.
Metz R; Delgado M; Keiling R; Cappelaere P; Armand JP; Prevot G; Misset JL; Grimbert J; Mathe G
Invest New Drugs; 1985; 3(2):163-6. PubMed ID: 4019119
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin (MOF-Strep) in patients with disseminated pancreatic carcinoma.
Sordillo PP; Magill GB
Am J Clin Oncol; 1982 Jun; 5(3):277-9. PubMed ID: 6282110
[TBL] [Abstract][Full Text] [Related]
14. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
Buroker TR; Moertel CG; Fleming TR; Everson LK; Cullinan SA; Krook JE; Mailliard JA; Marschke RF; Klaassen DJ; Laurie JA
J Clin Oncol; 1985 Dec; 3(12):1624-31. PubMed ID: 2933492
[TBL] [Abstract][Full Text] [Related]
15. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
[No Abstract] [Full Text] [Related]
16. Combination chemotherapy with adriamycin and streptozotocin. I. Clinical results in patients with advanced sarcoma.
Chang P; Wiernik PH
Clin Pharmacol Ther; 1976 Nov; 20(5):605-10. PubMed ID: 135666
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of metastatic gastrointestinal neoplasms with 5-fluorouracil and streptozotocin.
Seligman M; Bukowski RM; Groppe CW; Weick JK; Hewlett JS; Greenstreet RL
Cancer Treat Rep; 1977 Oct; 61(7):1375-7. PubMed ID: 201379
[No Abstract] [Full Text] [Related]
18. 1.3 Bis-(2 chloroethyl)-1-nitrosourea and streptozotocin chemotherapy.
Lokich JJ; Chawla PL; Frei E
Clin Pharmacol Ther; 1975 Mar; 17(3):374-8. PubMed ID: 123490
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial.
Chlebowski RT; Hestorff R; Sardoff L; Weiner J; Bateman JR
Cancer; 1978 Dec; 42(6):2546-52. PubMed ID: 365313
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide plus 5-FU versus 5-FU alone in advanced gastric carcinoma.
Chlebowski RT; Weiner JM; Silverberg I; Glass A; Bateman JR
Oncology; 1985; 42(3):141-3. PubMed ID: 3889759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
